$1,200.00
Somatropin is a recombinant human growth hormone (rhGH) with the 191 amino acid sequence of the mature protein produced by the human pituitary gland. It is used in laboratory animal studies of growth hormone receptor signalling and IGF-1. Omnitrope is a registered trademark of Sandoz for a prescription somatropin medicine that is authorized in Canada and the United States. This listing is laboratory research material and is not that medicine.
Omnitrope is a registered trademark of Sandoz for a prescription somatropin medicine. Omnitrope was approved by the FDA in 2006 under application BLA 021426 and is authorized and marketed in Canada by Sandoz Canada Incorporated. The material offered on this page is laboratory research material. It is not Omnitrope, it is not supplied by Sandoz, it is not a licensed or authorized medicine, and it is not supplied for any medical purpose.
Somatropin is a recombinantly produced form of human growth hormone (hGH). It has the same 191 amino acid sequence as the mature protein encoded by the human growth hormone gene. In the scientific literature, recombinant human growth hormone is widely used to study the endocrine control of growth and metabolism. Research focuses on its downstream signalling, in particular signalling to the liver to secrete Insulin like Growth Factor 1 (IGF-1), which has been studied in relation to growth, bone and the metabolism of lipids and carbohydrates.
Technical Specifications
Mechanism of Action (Research Context)
Research into somatropin concerns growth hormone signalling:
Storage and Handling
Testing and Quality Control
Every batch undergoes:
HPLC and mass spectrometry characterize chemical purity and identity. They do not measure biological activity, and no potency testing is performed or implied.
For laboratory research use only. Not for human or veterinary use.
Further reading